# Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

> **NCT01503177** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 15 (actual)

## Conditions studied

- Recurrent Malignant Mesothelioma
- Stage IA Malignant Mesothelioma
- Stage IB Malignant Mesothelioma
- Stage II Malignant Mesothelioma
- Stage III Malignant Mesothelioma
- Stage IV Malignant Mesothelioma

## Interventions

- **BIOLOGICAL:** oncolytic measles virus encoding thyroidal sodium iodide symporter
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** single photon emission computed tomography
- **PROCEDURE:** computed tomography

## Key facts

- **NCT ID:** NCT01503177
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2019-04-11
- **Final completion:** 2019-04-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01503177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01503177, "Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01503177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*